ETFMG Alternative Harvest ETF
Latest ETFMG Alternative Harvest ETF News and Updates

Gauging the Bullish-Bearish Sentiment on Aphria
The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

Analysts’ Estimates for Canopy Growth’s Earnings
Canopy Growth (WEED) (CGC) is expected to report a loss per share of ~0.15 Canadian dollars.

Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.

Cronos Group Invests in the Future
Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.

Aurora Cannabis: Analysts’ Projections
Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

Does Cronos Group Look Expensive Compared to Its Peers?
Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.

Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

Cannabis Legalization: Four Governors Met in New York
The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

Comparing the Valuation Multiples of Cannabis Stocks
In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.

iAnthus to Open Three Dispensaries in Florida by End of 2018
Today, iAnthus Capital Holdings (ITHUF) announced it will open its first dispensary in Florida on December 19.

Gundlach Compares Cannabis to Bitcoin
Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.

Big News: Cannabis Edibles in Alberta Stores
Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

Kamala Harris: Presidential Candidate for Legalizing Marijuana
Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.

Cannabis Stocks Continue to Struggle on the Last Day of April
The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.

Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

What Analysts Estimate for Cannabis Companies’ Earnings Margins
Let’s now look at how capacity expansion could translate into cannabis companies’ margins.

Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

Why Canopy Growth Is a ‘Buy’ before Its Earnings
Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

Curaleaf Opens Medical Marijuana Dispensary in Tallahassee
On November 16, Curaleaf Holdings announced that the company opened Tallahassee’s largest medical marijuana dispensary.

Cannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.

How Analysts View Cresco Labs before Its Q1 Release
Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.

CGC: How the Future Looks Under Its New CEO
On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.

Cannabis Stocks Had a Mixed Performance Last Week
Cannabis ETFs traded on a largely negative note last week.

IIPR Stock Moves Higher after New Debt Is Raised
Last week, Innovative Industrial Properties (IIPR) offered $125 million in senior notes, giving initial investors the option to exercise $18.75 million in additional principal amount notes.

Aurora Cannabis Releases Update on Cannabis 2.0
Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.

Cannabis Stocks: What Happens in a Recession?
As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

What’s the Market Potential for CBD?
The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

Considerations for Investors in Marijuana or Cryptocurrencies
The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.

Will Mexico Legalize Cannabis by the End of the Month?
With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.

One Chart That Shows What Makes Cannabis Attractive to Altria
As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.

Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

Why Origin House’s Acquisition Is Vital for Cresco Labs
On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.

Comparing GW Pharmaceuticals’ Returns to Peers
GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.

OrganiGram Receives Expansion License from Health Canada
On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.

Comparing Cannabis Stocks’ Valuation Multiples in November
Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.

Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?
On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.

OrganiGram Stock Falls after Disappointing Q3 Earnings
Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.

Aurora Cannabis Appoints New Chief Commercial Officer
As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.

Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%
Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.

Is Aphria or OrganiGram a Better Buy for Investors?
Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.

What to Expect from OrganiGram’s Q3 Earnings
OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.

Aphria Stock Rose More than 8% after Stifel’s Upgrade
Aphria (NYSE:APHA) received a bullish call from Stifel. On Monday, Stifel upgraded the stock from a “hold” to a “buy” rating.

Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand
Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

Why Did Raymond James Downgrade OrganiGram?
On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.

Green Thumb Keeps Expanding Its Operations in Las Vegas
On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

Canopy Growth Announces Initiatives to Regain Market Share
In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.

Why Canadian Cannabis Sales Dipped Slightly in April
In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.

MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.
- 1
- 2
- 3
- ...
- 7
- Next Page »